Risk Assessment Among Prostate Cancer Patients Receiving Primary Androgen Deprivation Therapy
AUTOR(ES)
Cooperberg, Matthew R.
FONTE
American Society of Clinical Oncology
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=2744272Documentos Relacionados
- Risk factors for bone loss with prostate cancer in Korean men not receiving androgen deprivation therapy
- Radiation therapy and androgen deprivation in the management of high risk prostate cancer
- Does androgen deprivation therapy in patients with prostate cancer protect from COVID-19?
- Tailored treatment including radical prostatectomy and radiation therapy + androgen deprivation therapy versus exclusive radical prostatectomy in high-risk prostate cancer patients: results from a prospective study
- Optimal duration of androgen deprivation therapy following radiation therapy in intermediate- or high-risk non-metastatic prostate cancer: A systematic review and meta-analysis